Civista Bancshares, Inc. (FRA:44Q)
16.90
-0.20 (-1.17%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | - | 31.68 | 42.96 | 39.43 | 40.55 | 32.19 | Upgrade |
Depreciation & Amortization | - | 11.03 | 12.34 | 5.75 | 2.87 | 3.17 | Upgrade |
Gain (Loss) on Sale of Assets | - | -0.25 | -0.08 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | 0.68 | 0.49 | 1.48 | -0.6 | 1.08 | Upgrade |
Provision for Credit Losses | - | 5.36 | 4.44 | 1.75 | 0.83 | 10.11 | Upgrade |
Net Decrease (Increase) in Loans Originated / Sold - Operating | - | 5.5 | 1.87 | 4.69 | 13.07 | 3.85 | Upgrade |
Accrued Interest Receivable | - | -0.63 | -1.64 | -2.05 | 2.04 | -2.33 | Upgrade |
Change in Other Net Operating Assets | - | 3.68 | -1.53 | -20.24 | -0.15 | 0.92 | Upgrade |
Other Operating Activities | - | -3.37 | -2.4 | -3.84 | -11.93 | -6.04 | Upgrade |
Operating Cash Flow | - | 48.25 | 62.7 | 25.18 | 40.76 | 32.65 | Upgrade |
Operating Cash Flow Growth | - | -23.05% | 148.97% | -38.22% | 24.83% | -15.84% | Upgrade |
Capital Expenditures | - | -4.19 | -3.43 | -6.51 | -1.93 | -1.97 | Upgrade |
Sale of Property, Plant and Equipment | - | 4.24 | - | 0.18 | 0.01 | 0.01 | Upgrade |
Cash Acquisitions | - | - | - | -51.64 | - | - | Upgrade |
Investment in Securities | - | -38.67 | 12.82 | -37.21 | -200.31 | 4.33 | Upgrade |
Net Decrease (Increase) in Loans Originated / Sold - Investing | - | -221.25 | -314.5 | -315.19 | 71.07 | -343.35 | Upgrade |
Other Investing Activities | - | 0.76 | -6.68 | - | 0.54 | - | Upgrade |
Investing Cash Flow | - | -258.8 | -311.78 | -410.36 | -130.5 | -340.98 | Upgrade |
Short-Term Debt Issued | - | 1 | - | 393.7 | - | 10.24 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 73.39 | 183.7 | Upgrade |
Total Debt Issued | - | 1 | - | 393.7 | 73.39 | 193.94 | Upgrade |
Short-Term Debt Repaid | - | - | -26.33 | -0.35 | -3.42 | -101.5 | Upgrade |
Long-Term Debt Repaid | - | -4.31 | -61.36 | -135.75 | -50 | -183.7 | Upgrade |
Total Debt Repaid | - | -4.31 | -87.69 | -136.11 | -53.42 | -285.2 | Upgrade |
Net Debt Issued (Repaid) | - | -3.31 | -87.69 | 257.59 | 19.97 | -91.26 | Upgrade |
Repurchase of Common Stock | - | -0.16 | -1.63 | -16.89 | -22.31 | -13.45 | Upgrade |
Common Dividends Paid | - | -10.06 | -9.6 | -8.49 | -8.04 | -7.12 | Upgrade |
Total Dividends Paid | - | -10.06 | -9.6 | -8.49 | -8.04 | -7.12 | Upgrade |
Net Increase (Decrease) in Deposit Accounts | - | 226.84 | 365.04 | -67.91 | 227.3 | 510.63 | Upgrade |
Financing Cash Flow | - | 213.3 | 266.13 | 164.3 | 216.93 | 398.8 | Upgrade |
Net Cash Flow | - | 2.75 | 17.05 | -220.88 | 127.19 | 90.47 | Upgrade |
Free Cash Flow | - | 44.06 | 59.27 | 18.68 | 38.83 | 30.68 | Upgrade |
Free Cash Flow Growth | - | -25.66% | 217.37% | -51.91% | 26.57% | -13.81% | Upgrade |
Free Cash Flow Margin | - | 29.55% | 37.46% | 13.58% | 30.81% | 28.46% | Upgrade |
Free Cash Flow Per Share | - | 2.86 | 3.91 | 1.25 | 2.53 | 1.91 | Upgrade |
Cash Interest Paid | - | 89.99 | 48.38 | 10.7 | 6.21 | 10.21 | Upgrade |
Cash Income Tax Paid | - | 4.89 | 9.51 | 3.15 | 6.18 | 7.1 | Upgrade |
Source: S&P Global Market Intelligence. Banks template. Financial Sources.